Palatine acquires the MOLE clinic

Palatine’s Impact Fund has acquired a majority shareholding in skin cancer screening business the MOLE Clinic from Hebe Group. Financial details of the transaction have not been disclosed, but Palatine said it planned to target significant expansion of the business with the addition of six new clinics over the next three years. The MOLE Clinic…